Clinical trial
Identification of Novel Biomarkers to Aid in the Detection of Occult Cancer in Patients With Venous Thromboembolism
NCT03781531 is registered in ClinicalTrials.gov with Danderyd Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Identification of Novel Biomarkers to Aid in the Detection of Occult Cancer in Patients With Venous Thromboembolism
- Lead sponsor
- Danderyd Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- March 1, 2017
- Completion date
- December 31, 2028
- Enrollment
- 1,000 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
cancer, venous thromboembolism